182 related articles for article (PubMed ID: 9139553)
21. Evaluation of colchicine therapy in primary biliary cirrhosis.
Bodenheimer H; Schaffner F; Pezzullo J
Gastroenterology; 1988 Jul; 95(1):124-9. PubMed ID: 3286360
[TBL] [Abstract][Full Text] [Related]
22. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group.
Poupon RE; Balkau B; Eschwège E; Poupon R
N Engl J Med; 1991 May; 324(22):1548-54. PubMed ID: 1674105
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of interleukin-1 beta in primary biliary cirrhosis: relationship to treatment with methotrexate or colchicine and disease progression.
Miller LC; Sharma A; McKusick AF; Tassoni JP; Dinarello CA; Kaplan MM
Hepatology; 1995 Aug; 22(2):518-24. PubMed ID: 7635420
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic trials in primary biliary cirrhosis.
Sherlock S
QJM; 1994 Nov; 87(11):701-3. PubMed ID: 7820545
[No Abstract] [Full Text] [Related]
25. Characterisation of patients with primary biliary cirrhosis responding to long term ursodeoxycholic acid treatment.
Leuschner M; Dietrich CF; You T; Seidl C; Raedle J; Herrmann G; Ackermann H; Leuschner U
Gut; 2000 Jan; 46(1):121-6. PubMed ID: 10601067
[TBL] [Abstract][Full Text] [Related]
26. Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome.
Corpechot C; Chazouillères O; Poupon R
J Hepatol; 2011 Dec; 55(6):1361-7. PubMed ID: 21703194
[TBL] [Abstract][Full Text] [Related]
27. Pilot study of low dose oral methotrexate treatment for primary biliary cirrhosis.
Bergasa NV; Jones A; Kleiner DE; Rabin L; Park Y; Wells MC; Hoofnagle JH
Am J Gastroenterol; 1996 Feb; 91(2):295-9. PubMed ID: 8607496
[TBL] [Abstract][Full Text] [Related]
28. Primary biliary cirrhosis.
Kaplan MM; Gershwin ME
N Engl J Med; 2005 Sep; 353(12):1261-73. PubMed ID: 16177252
[No Abstract] [Full Text] [Related]
29. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid.
Kuiper EM; Hansen BE; de Vries RA; den Ouden-Muller JW; van Ditzhuijsen TJ; Haagsma EB; Houben MH; Witteman BJ; van Erpecum KJ; van Buuren HR;
Gastroenterology; 2009 Apr; 136(4):1281-7. PubMed ID: 19208346
[TBL] [Abstract][Full Text] [Related]
30. Methotrexate for treatment of primary biliary cirrhosis.
Bonis PA; Kaplan M
Hepatology; 2006 Mar; 43(3):632; author reply 632-3. PubMed ID: 16496314
[No Abstract] [Full Text] [Related]
31. Long-term response of primary biliary cirrhosis (stage I) to therapy with ursodeoxycholic acid.
Tromm A; May B; Klein CG; Klein R; Fisseler-Eckhoff A; Griga T
Hepatogastroenterology; 2005; 52(63):753-6. PubMed ID: 15966198
[TBL] [Abstract][Full Text] [Related]
32. Primary biliary cirrhosis treated with low-dose oral pulse methotrexate.
Kaplan MM; Knox TA; Arora SA
Ann Intern Med; 1988 Sep; 109(5):429-31. PubMed ID: 3408057
[No Abstract] [Full Text] [Related]
33. Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid.
Talwalkar JA; Angulo P; Keach JC; Petz JL; Jorgensen RA; Lindor KD
J Clin Gastroenterol; 2005 Feb; 39(2):168-71. PubMed ID: 15681915
[TBL] [Abstract][Full Text] [Related]
34. Predictive scores in primary biliary cirrhosis: a retrospective single center analysis of 204 patients.
Weinmann A; Sattler T; Unold HP; Grambihler A; Teufel A; Koch S; Schuchmann M; Biesterfeld S; Wörns MA; Galle PR; Schulze-Bergkamen H
J Clin Gastroenterol; 2015; 49(5):438-47. PubMed ID: 25014239
[TBL] [Abstract][Full Text] [Related]
35. Methotrexate for primary biliary cirrhosis: who is to be trusted?
Selmi C; Podda M
Dig Dis Sci; 2010 Nov; 55(11):3013-5. PubMed ID: 20945095
[No Abstract] [Full Text] [Related]
36. Adjuvant cholylsarcosine during ursodeoxycholic acid treatment of primary biliary cirrhosis.
Ricci P; Hofmann AF; Hagey LR; Jorgensen RA; Rolland Dickson E; Lindor KD
Dig Dis Sci; 1998 Jun; 43(6):1292-5. PubMed ID: 9635620
[TBL] [Abstract][Full Text] [Related]
37. Low-dose methotrexate in primary biliary cirrhosis.
Bonis PA; Kaplan MM
Gastroenterology; 1999 Dec; 117(6):1510-3. PubMed ID: 10610345
[No Abstract] [Full Text] [Related]
38. Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis.
Combes B; Emerson SS; Flye NL; Munoz SJ; Luketic VA; Mayo MJ; McCashland TM; Zetterman RK; Peters MG; Di Bisceglie AM; Benner KG; Kowdley KV; Carithers RL; Rosoff L; Garcia-Tsao G; Boyer JL; Boyer TD; Martinez EJ; Bass NM; Lake JR; Barnes DS; Bonacini M; Lindsay KL; Mills AS; Markin RS; Rubin R; West AB; Wheeler DE; Contos MJ; Hofmann AF
Hepatology; 2005 Nov; 42(5):1184-93. PubMed ID: 16250039
[TBL] [Abstract][Full Text] [Related]
39. Combined treatment with methotrexate and ursodeoxycholic acid in non-cirrhotic primary biliary cirrhosis.
Van Steenbergen W; Sciot R; Van Eyken P; Desmet V; Fevery J
Acta Clin Belg; 1996; 51(1):8-18. PubMed ID: 8669166
[TBL] [Abstract][Full Text] [Related]
40. Clinical trial: randomized controlled study of zidovudine and lamivudine for patients with primary biliary cirrhosis stabilized on ursodiol.
Mason AL; Lindor KD; Bacon BR; Vincent C; Neuberger JM; Wasilenko ST
Aliment Pharmacol Ther; 2008 Oct; 28(7):886-94. PubMed ID: 18627363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
